RG

Ranganathan Govindarajan

Director Director DIN 02401464
DIN 02401464 First appointment Sep 2007 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Ranganathan Govindarajan

Data last updated:

Ranganathan Govindarajan was a Director at Ceego Labs Private Limited (2007–2010) and Director at Sresan Pharmaceuticals Limited (from 2009). The companies operate in Pharma.

DIN 02401464
Primary Designation Director
Industry Pharma
First Appointment 01 Sep 2007
Oldest Company Age 36 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ceego Labs Private Limited U24121TN1995PTC033098
Director01 Sep 20071995₹28.61 Cr (FY 2025)Active
Sresan Pharmaceuticals Limited U24231TN1990PLC019816
Director02 Apr 20091990Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sresan Pharmaceuticals Limited
Ceego Labs Private Limited
Premium access

Shareholding and investment profile for Ranganathan Govindarajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranganathan Govindarajan

Ranganathan Govindarajan was first appointed on 01 Sep 2007 as Director at Ceego Labs Private Limited. The most recent appointment on record is 02 Apr 2009 at Sresan Pharmaceuticals Limited.

Ranganathan Govindarajan held 2 earlier board appointments: Ceego Labs Private Limited (Director, 01 Sep 2007 to 18 Oct 2010); Sresan Pharmaceuticals Limited (Director, from 02 Apr 2009).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available